European Commission's first deal for COVID-19 vaccine takes effect
01-09-2020
European Commission commits €100bn for research and innovation
08-06-2018
Quinta / Shutterstock.com
The European Commission will unveil plans to make supplementary protection certificates (SPC) more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
European Commission, SPC, national, compulsory licensing, patents
